New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 18, 2014
10:57 EDTPSEC, YPF, ICPT, ACRX, TAX, CALL, ARWR, CREE, OPK, KINGOptions with decreasing implied volatility
Options with decreasing implied volatility: ARWR ICPT KING CALL YPF OPK TAX PSEC CREE ACRX
News For ARWR;ICPT;KING;CALL;YPF;OPK;TAX;PSEC;CREE;ACRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 15, 2014
10:25 EDTPSECProspect Capital to host business news update conference call
Subscribe for More Information
10:19 EDTOPKOPKO Health soars after entering hGP-CTP agreement with Pfizer
Subscribe for More Information
09:38 EDTOPKActive equity options trading
Subscribe for More Information
09:27 EDTOPKOn The Fly: Pre-market Movers
HIGHER: Opko Health (OPK), up 13.1% after Pfizer (PFE) and OPKO Health enter into global agreement for hGH-CTP... Cirrus Logic (CRUS), up 7.5% after being upgraded to Overweight from Underweight at Barclays... PetSmart (PETM), up 4.7% after being acquired by BC Partners led consortium for $83 per share... Sohu.com (SOHU), up 3% after being upgraded to Overweight from Neutral at JPMorgan... Oracle (ORCL), up 2.2% after receiving FedRAMP provisional authority to operate. LOWER: Unwired Planet (UPIP), down 25.7% after commenting on Google (GOOG) Markman ruling... EXCO Resources (XCO), down 13% after suspending its dividend.
08:58 EDTICPTIntercept reinstated with a Buy at BofA/Merrill
Subscribe for More Information
08:02 EDTOPKPfizer, OPKO Health enter into global agreement for hGH-CTP
Subscribe for More Information
07:33 EDTARWRArrowhead submits IND for ARC-520 to begin Phase 2b studies
Arrowhead Research announced that it submitted an Investigational New Drug application to the U.S. Food and Drug Administration for ARC-520, itís drug candidate for the treatment of chronic hepatitis B virus infection. Arrowhead plans to submit additional clinical trial authorization applications with regulatory authorities in various jurisdictions in Europe and Asia. Pending national regulatory review and approval, Arrowhead intends to initiate two Phase 2b, multicenter, randomized, double-blind, placebo-controlled, multi-dose studies to determine the depth of hepatitis B surface antigen reduction following ARC-520 injection in combination with entecavir or tenofovir in patients with chronic immune active HBV infection. The Heparc-2002 study is planned to include patients who are negative for hepatitis B e-antigen at screening and the Heparc-2003 study is planned to include patients who are positive for HBeAg at screening. The primary objective is to evaluate the depth of HBsAg decline in response to multiple doses of ARC-520 compared to placebo in patients with chronic HBV infection as a measure of drug activity. Secondary objectives are to assess measures of safety and tolerability and to evaluate multi-dose pharmacokinetics of ARC-520 in patients with chronic HBV infection when co-administered with a fixed dose of entecavir or tenofovir, in addition to other exploratory safety and pharmacodynamic objectives.
December 11, 2014
13:09 EDTARWRArrowhead mentioned positively by Agora Financial
Agora Financial believes investors can "double [their] money ó virtually overnight." and have a "realistic chance" to make "up to 10 times [their] money" by investing in Arrowhead Research, according to a new research report from the firm. Arrowhead shares are up nearly 10% to $5.98 in afternoon trading. Reference Link
08:57 EDTICPTLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
December 10, 2014
08:04 EDTACRXRoth Capital to hold an event
Corporate Access Event 2014 is being held in Park City, Utah on December 10-12.
06:00 EDTOPKStocks with implied volatility above IV index mean; DG OPK
Stocks with implied volatility above IV index mean; OPKO Health (OPK) 36, Dollar General (DG) 37 according to iVolatility.
December 9, 2014
13:32 EDTYPFYPF downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
10:27 EDTPSECOptions with increasing implied volatility
Subscribe for More Information
06:07 EDTOPKStocks with implied volatility above IV index mean; DG OPK
Stocks with implied volatility above IV index mean; OPKO Health (OPK) 41, Dollar General (DG) 37 according to iVolatility.
December 8, 2014
10:42 EDTPSECOptions with increasing implied volatility
Subscribe for More Information
09:20 EDTPSECOn The Fly: Pre-market Movers
Subscribe for More Information
08:43 EDTPSECProspect Capital suspends ATM equitiy issuance, reduces dividends
Prospect Capital announced that, in light of current share price levels, Prospect has suspended at-the-market equity issuances for the indefinite future. Prospect will continue to take a disciplined approach to any future potential equity issuance, the company said. As of September 30, Prospect's asset concentration in the energy industry stood at 5.1%, including Prospect's first lien senior secured loans where third parties bear first loss capital risk. As of December 31, 2013, Prospect's loan non-accrual rate stood at 0.32%, weighted average portfolio net leverage stood at 4.49 times earnings before interest, taxes, depreciation, and amortization and trailing twelve month first lien origination mix stood at 58.3%. Prospect announced it has declared reduced monthly cash dividends to shareholders in the following amounts and with the following record and payment dates: 8.333c per share for February 2015, with a record date of February 27, 2015 and payment date of March 19, 2015; 8.333c per share for March 2015, with a record date of March 31, 2015 and payment date of April 23, 2015; and 8.333c per share for April 2015, with a record date of April 30, 2015 and payment date of May 21, 2015. "As our updated credit statistics show, we have elected in the past year to take on less risk and focus on higher earnings quality by increasing our percentage of first lien loans and accepting lower interest rates in this yield compressed environment. We have not chased higher yields that we believe do not compensate for risk. While we have more than covered our prior dividends out of taxable earnings, we are reducing the next three declared dividends from past levels because we believe we should pay a dividend that is no more than our minimum expected net investment income, based on our expectations over the next twelve months," said John Barry III, Chairman and CEO of Prospect.
06:07 EDTTAXLiberty Tax reports Q2 adjusted EPS (74c), consensus (74c)
Subscribe for More Information
December 5, 2014
06:06 EDTICPTIntercept announces publication of meta-analysis from Global PBC Study Group
Subscribe for More Information
05:54 EDTOPKStocks with implied volatility movement; BSX OPK
Stocks with implied volatility movement; Boston Scientific (BSX) 32, OPKO Health (OPK) 37 according to iVolatility.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use